Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Pfizer's Ponsegromab?
Ponsegromab is a monoclonal antibody commercialized by Pfizer, with a leading Phase II program in Congestive Heart Failure (Heart Failure)....
Data Insights
Ponsegromab by Pfizer for Congestive Heart Failure (Heart Failure): Likelihood of Approval
Ponsegromab is under clinical development by Pfizer and currently in Phase II for Congestive Heart Failure (Heart Failure). According to...